Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: guarantee (67), certify (28), warrant (16)

Clinical Divisional Lead JD March 2022

Description: Job Description Job Title: Clinical Divisional Lead Directorate: Clinical Research Network (CRN) Wessex Accountable to: CRN Wessex Clinical Dire
Url: /Media/Southampton-Clinical-Research/Downloads/Clinical-Divisional-Lead-JD-March-2022.pdf

InP-BEAM

Description: Chemotherapy Protocol LYMPHOMA CARMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (BEAM) Inpatient Regimen Regimen Lymphoma – InP-BEAM (split)-Carmu
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-BEAM.pdf

InP RCODOX M(66) cyclophosphamide doxorubicin methotrexate rituximab vincristine

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-METHOTREXATE-RITUXIMAB-VINCRISTINE (RCODOX-M) 66 years and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RCODOX-M66-cyclophosphamide-doxorubicin-methotrexate-rituximab-vincristine.pdf

InP RCODOX M(65) cyclophosphamide doxorubicin methotrexate rituximab vincristine

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-METHOTREXATE-RITUXIMAB-VINCRISTINE (RCODOX-M) 65 years and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RCODOX-M65-cyclophosphamide-doxorubicin-methotrexate-rituximab-vincristine.pdf

DRC-Cyclophosphamide-Dexamethasone-Rituximab

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE - DEXAMETHASONE – RITUXIMAB (DRC) Regimen • Lymphoma – DRC – Cyclophosphamide – Dexamethasone - Rituximab Indica
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/DRC-Cyclophosphamide-Dexamethasone-Rituximab.pdf

Docetaxel-Fluorouracil-Folinic Acid-Oxaliplatin (FLOT)

Description: Chemotherapy Protocol UPPER GASTROINTESTINAL CANCER DOCETAXEL-FLUOROURACIL-FOLINIC ACID-OXALIPLATIN (FLOT) Regimen • Upper GI – D
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Docetaxel-Fluorouracil-Folinic-Acid-Oxaliplatin-FLOT.pdf

Procedure for BIA using SFB7

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assuran
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-BIA-using-SFB7.pdf

Neonatal community outreach team (NCOT) - patient information

Description: This factsheet explains how the neonatal community outreach team (NCOT) can help and support you.
Url: /Media/UHS-website-2019/Patientinformation/Neonatal/Neonatal-community-outreach-team-NCOT-872-PIL.pdf

UHS ICE EDGE compatibillty

Description: UHS ICE was upgraded to version 7.1.7 in April 2022 which includes 'Edge' browser compatibility.
Url: /Media/UHS-website-2019/Docs/Services/Pathology/ICE/UHS-ICE-EDGE-compatabillty.pdf

MyelomaBortezomib IV DexamethasonePabinostatThalidomide 21day Ver1.1

Description: Chemotherapy Protocol MULTIPLE MYELOMA BORTEZOMIB (IV)-DEXAMETHASONE-PANOBINOSTAT-THALIDOMIDE Regimen (21 day) • Multiple Myeloma – Bortezomib (IV)-Dexamethasone-Panob
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaBortezomib-IV-DexamethasonePabinostatThalidomide-21day-Ver1.1.pdf

211 to 220 of 1000

Previous … 20 21 22 23 24 … Next